Canopy Growth and Mettrum Announce Respective Shareholder Approvals of the Plan of Arrangement SMITHS FALLS and TORONTO, ON, Jan. 27, 2017 /CNW/ – Canopy Growth Corporation (“Canopy Growth”) (TSX:...
Canopy Growth Corporation Comments on the Year that was 2016 SMITHS FALLS, ON, Jan. 3, 2017 /CNW/ – As a leader in Canada’s medical cannabis industry, Canopy Growth Corporation...
On the same evening earlier this month that Canopy Growth (TSX: CGC) (OTC: TWMJF) announced the acquisition of Mettrum (TSXV: MT) (OTC: MQTRF), Mettrum issued a press release providing...
Perhaps the biggest story of 2016 in the cannabis capital markets was the surge in prices and the amount of capital raised for the cannabis industry in Canada during...
Canopy Growth enters into agreement to acquire Mettrum Significant additional production capacity and brand diversification to Canopy Growth, Canada’s leading cannabis company Canopy Growth will add two national brands...
Minister Hehr announces a new reimbursement policy for Cannabis for Medical Purposes VANCOUVER, Nov. 22, 2016 /CNW/ – The Honourable Kent Hehr, Minister of Veterans Affairs and Associate Minister of...
Mettrum Announces Strategic Acquisition to Further Accelerate Growth and Research Profile Mettrum acquires Apollo Applied Research with growing base of 5,400 active clients TORONTO, ONTARIO–(Marketwired – Nov. 16, 2016)...
Mettrum Announces Second Quarter 2017 Financial Results Q2 2017 versus Q2 2016 Financial Highlights: – Revenues increased 180% to $4,790,022 – Grams sold increased 127% to 480,340 grams –...
After what seems like an unacceptably long delay, Health Canada, which oversees the Canadian medical cannabis program, ACMPR, reported data for the quarter ending 06/30/16 on Friday. The number of patients enrolled in...
Mettrum to Sell Non-Core Subsidiary for $7 Million and Enters Three Year Product Supply Agreement Strategic Transaction Opens New Sales Channel Opportunity to Canada’s Largest Construction Labor Union TORONTO,...
Mettrum (TSXV: MT) (OTC: MQTRF) recently reported the second highest quarterly sales among the 8 publicly-traded Canadian medical cannabis licensed producers, trailing only Canopy Growth. Though the company has made substantial...
Mettrum Announces First Quarter 2017 Financial Results TORONTO, ONTARIO, Aug 22, 2016 (Marketwired via COMTEX) — TORONTO, ONTARIO–(Marketwired – Aug 22, 2016) – Q1 2017 versus Q4 2016...
Note: Shortly after publication, each company boosted the size of its offering by $5mm, with Canopy Growth’s deal increasing to $30mm and Mettrum’s to $15m, for a total of...
When Justin Trudeau and the Liberal Party won a majority of seats in the Canadian Parliament elections in October last year, it set off a quick pop in the...
Earlier this week, Health Canada, which oversees the Canadian medical cannabis program, MMPR, reported data for the quarter ending 03/31/16. The number of patients enrolled in the program grew 35.2% from...
Mettrum Announces Fourth Quarter and Full Fiscal Year 2016 Financial Results TORONTO, ONTARIO–(Marketwired – June 29, 2016) – Q4 2016 versus Q3 Financial Highlights: Revenues increased 35% to $2,714,468...
Despite a rapidly growing underlying industry, investors in the publicly-traded cannabis stocks have been dodging landmines for several years now, with few companies producing solid returns so far and...
Like several of its licensed producer peers in Canada, including Canopy Growth (TSXV:CGC) (OTC:TWMJF), which has raised capital twice since October’s election of new PM Justin Trudeau, as...
Mettrum Receives License Amendment for the Sale of Medical Cannabis and Extracts at its 60,000 Square Foot Facility in Bowmanville TORONTO, ONTARIO–(Marketwired – May 9, 2016) – Mettrum Health...
Mettrum (TSXV:MT) announced this morning that it has raised at least $5mm through a “bought” offering led by underwriter Cormark Securities, which has agreed to purchase 3.334mm shares for...
Alan Brochstein, CFA, discussed the “State of the Legal Canadian Cannabis Industry” at the eMoneyShow Virtual Conference on 10/30/15: One of the biggest barriers to investing in cannabis companies is that...
